click below
click below
Normal Size Small Size show me how
NURS 572 Pharm 28
Opioids, nonopioid centrally acting analgesics
| Question | Answer |
|---|---|
| MOA opioid agonists | activate Mu (--> resp dep) and Kappa (--> psychotomimetic, diuretic) |
| strong opioids given oral, IM, rectal (3) | morphine, hydromorphone, oxymorphone |
| very short acting opioids (2) | meperidine, remifentanyl |
| meperidine uses/ADRs | labor/delivery, neurotoxic metabolite (avoid drug), anticholinergic (watch tachy) |
| remifentanyl | break through pain, short acting, metab by plasma esterases |
| long-acting opioids (2) | methadone, levorphanol |
| methadone uses | pain, maintenance, detox |
| levorphanol class | long acting opiate agonist |
| chronic pain opioids (3) | fentanyl, alfentanil, sufentanyl |
| routes of admin fentanyls | inj, ITS, transdermal, lozenge, lollipop, buccal, nasal spray |
| moderate efficacy opioids (3) | codeline, oxycodone, hydrocodone |
| codeine | combo, very limiting SEs n/v |
| oxycodone | alone or combo |
| hydrocodone | combo only |
| MOA mixed agonist/antagonist opioids | activate either mu/kappa, antagonize the other |
| benefit/limitation mixed opioids | raises resp depr ceiling(+), but pyschotomimetic reactions |
| name 4 mixed opioids | pentazocaine, nalbuphine, butorphanol, buprenorphine |
| which 2 mixed opioids contraindicated cardiac pts due to increased cardiac load | pentazocaine (contains naloxone too), butorphanol |
| class of nalbuphine | mixed opioid |
| class of buprenorphine | mixed opioid with diff actions at mu/kappa |
| class of penazocaine | mixed opioid, oral combo with naloxone, or injection |
| name 4 opiate antagonists that can lead to withdrawal if pt is opioid tolerant | naloxone, naltrexone, methyl-naltrexone, alvimopan |
| class, use naloxone | opioid antagonist. rapid, short acting block mu/kappa. detox/cravings |
| class, use of naltrexone | opioid antagonist. maintenance post detox. doesn't prevent cravings |
| class, use of alvimpoan | only post-op ileus (antagonizes SE of urinary retention). strict controls, in pt only |
| opioid ADRs that do NOT develop tolerance | miosis, consitpation |
| opioid ADRS where tolerance develops | urinary retention, biliary colic, ICP increases, orthostatic hypoTN, emesis, sedation, decreased respirations, cough suppression |
| MOA non-opioid central acting analgesics | weak mu agonist, but either blocks reuptake Ser, Nor or both |
| class, moa tramadol | non opioid centrally acting analgesic blocks reuptake of nor, ser |
| class, moa tapentadol | non opioid centrally acting analgesic blocks reuptake of ser only |